EN
HI

WELCURE DRUGS & PHARMACEU Share price

WELCURE

MiscellaneousSmall

11.52

0.48 (-4.00%)
Last updated on 30 May, 2025 | 15:59 IST
BUYSELL
Today's High

12.60

Today's Low

11.40

52 Week Low

4.30

52 Week High

15.81

The current prices are delayed, login to your account for live prices

Welcure Drugs & Pharmaceuticals Chart

WELCURE DRUGS & PHARMACEU Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

40.19

Sector P/B

2.51

Sec. Div. Yield

101.48

WELCURE DRUGS & PHARMACEU Resistance and Support

Pivot 11.92

Resistance

First Resistance

12.42

Second Resistance

12.84

Third Resistance

13.34

Support

First Support

11.5

Second Support

11

Third Support

10.58

WELCURE DRUGS & PHARMACEU Futures & Options

Data Not Found

WELCURE DRUGS & PHARMACEU Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    0%

    Mutual Fund

    0%

    Insurance

    0%

    Foreign Institutional Investors

    0%

    Domestic Institutional Investors

    0%

    Retail

    100%

    Others

    0%

    Total Promoters
    MAR '24
    0%
    JUN '24
    0%
    SEP '24
    0%
    DEC '24
    0%

    WELCURE DRUGS & PHARMACEU Corporate Actions

    DateAgenda
    2025-05-29Audited Results
    2025-05-14Others
    2025-02-14Quarterly Results
    DateEvent TypeAgenda
    2025-05-29Board MeetingAudited Results
    2025-05-14Board MeetingOthers
    2025-02-14Board MeetingQuarterly Results

    WELCURE DRUGS & PHARMACEU News

    No Data Found

    About WELCURE DRUGS & PHARMACEU AboutThe

    NSE : 0  
    BSE : 524661  
    ISIN : INE331C01017  

    Welcure Drugs and Pharmaceuticals Limited (hereinafter referred to as ''The Company'' or ''WDPL'') was incorporated as a Public Limited Company under the Companies Act 1956 on 4th June 1992 and obtained the certificate of commencement of business on 19th June 1992. The registered office of the Company is situated at E-1052. Saraswati Vihar Delhi - 110 034.PRESENT BUSINESSPresently the Company is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets capsules and dry syrups. The Company is manufacturing over hundred varieties of formulations including antibiotics sulpha drugs vitamins analgesics antipyretics corticosteroids anti-malarials anti-dysentery anti-tuberculosis anti-diabetics tranquilisers sedatives and gastro intestinals. The products of the company have already been well accepted in the domestic markets and the Company has an established customer base.SWOT ANALYSISStrengths1.One of the Promoters is having over two decades and the other two promoters are having over a decade experience in the pharmaceutical industry.2.The Plant & Machinery taken by the company is a multipurpose plant on which other drugs can be produced apart from what company intends to manufacture.3.The technolgy required to manufacture of the drugs is indegenously available.4.Approval of first floor of factory by Drugs Control Department to systematically and properly utilise the space for expanded capacity.5.Major portion of bulk drugs will be used for captive consumption for manufacture of pharmaceuticals formulations.6.With the completion of the bulk drug unit the Company will have integrated facilities to manufacture intermediates bulk drugs and formulations.7.Subsidiary Company A.K.Laboratories Ltd. is producing 6 APA a critical drug intermediate used for manufacture of life saving antibiotic drugs like viz. Ampicillin Amoxycillin Cloxacillin and Cephalexin.Weaknesses1.Commercial production of the existing formulation unit was delayed by five months and bulk drug unit is expected to be delayed by approximately 18 months.2.The cost of the project and means of finance have not been appraised by any Bank/Financial Institution.3.Delay in Government approvals may affect the timely implementation of the project.Opportunities1.Products have a growing domestic market and good export potential.Threats1. Competition from existing and proposed manufacturers as is normal and prevalent in any industry.2.Changes in Drug Policy announced by the Government from time to time may have an impact on the operations of the Company.

    WELCURE DRUGS & PHARMACEU Management

    NamePosition
    Mr. Altaf Hussain Shah Managing Director & CFO
    Mrs. Deepika Krishnan Iyer Ind. Non-Executive Director
    Mr. Ashish Abbi Ind. Non-Executive Director
    Mr. Suraj Chagan Solanki Non Exe.Non Ind.Director
    Read More

    WELCURE DRUGS & PHARMACEU FAQs

    WELCURE DRUGS & PHARMACEU शेयर का खरीद मूल्य 11.52 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    WELCURE DRUGS & PHARMACEU शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    WELCURE DRUGS & PHARMACEU शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    WELCURE DRUGS & PHARMACEU शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    WELCURE DRUGS & PHARMACEU शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    WELCURE DRUGS & PHARMACEU का मार्केट कैप 129.61 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    WELCURE DRUGS & PHARMACEU शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 15.81 और 4.30 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    WELCURE DRUGS & PHARMACEU Share Key Metrics

    Volume
    2.53 L
    Market Cap
    129.61 CR
    LTQ@LTP
    100@11.52
    ATP
    11.82
    Var Margin
    100 %
    Circuit Range
    11.4-12.6
    Delivery %
    0 %
    Value
    29.91 L
    ASM/GSM
    No
    Market Lot
    1